Artificial Intelligence Enhanced Assessment of Speech Disorders

Overview

About this study

The purpose of this study is to create a large, well annotated speech-bank which can be used in artificial intelligence (AI) projects.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult (18 years or older).
  • Able to provide informed consent 
  • Able to provide samples in English.
  • U.S. based patient.

Exclusion Criteria:

  • Age < 18 years of age.
  • Unable to provide samples in English (i.e., need for interpreter flag in Epic).
  • Nonverbal / No speech.
  • HPP (High Profile Patient) status.
  • International patient.

Eligibility last updated 3/3/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Hugo Botha, M.B., Ch.B.

Open for enrollment

Contact information:

Victoria Stubbs

(507) 538-6394

speechnaip@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Cyril Varghese, M.D., M.S.

Open for enrollment

Contact information:

Victoria Stubbs

(507) 538-6394

speechnaip@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

William Freeman, M.D.

Open for enrollment

Contact information:

Victoria Stubbs

(507) 538-6394

speechnaip@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20534586

Mayo Clinic Footer